| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 135 | / | 2018 | ||||||||
| Date of issue: | 2018-11-29 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Interim consolidated report for the nine months of 2018 of Sopharma Group | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| 1.Financial report according to IFRS as at 30 September 2018 2.Notes to the financial report as at 30 September 2018 3.Management report as at 30 September 2018 4.Insider information as at 30 September 2018 5.Additional information as at 30 September 2018 6.Financial report according to BFCS standards as at 30 September 2018 7.Annex 9 as at 30 September 2018 8.Declaration as at 30 September 2018 | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Interim consolidated report for the nine months of 2018 of Sopharma Group.rar | Interim consolidated report for the nine months of 2018 of Sopharma Group | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2018-11-29 | Ognian Donev | Executive director | |||
Interim consolidated report for the nine months of 2018 of Sopharma Group.rar
